中文名 | ML221 |
英文名 | 5-[(4-Nitrobenzoyl)oxy]-2-[(2-pyrimidinylthio)methyl]-4H-pyran-4-one |
别名 | 化合物ML221 4-氧代-6-((嘧啶-2-基硫基)甲基)-4H-吡喃-3-基 4-硝基苯甲酸酯 |
英文别名 | ML221 ML-221 ML 221 ML 221 CS-2842 ML-221 4-Oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate 5-[(4-Nitrobenzoyl)oxy]-2-[(2-pyrimidinylthio)methyl]-4H-pyran-4-one 4H-Pyran-4-one, 5-[(4-nitrobenzoyl)oxy]-2-[(2-pyrimidinylthio)methyl]- |
CAS | 877636-42-5 |
化学式 | C17H11N3O6S |
分子量 | 385.35 |
密度 | 1.54±0.1 g/cm3(Predicted) |
沸点 | 624.1±55.0 °C(Predicted) |
溶解度 | DMSO: 可溶5mg/mL,澄清 (温热) |
酸度系数 | 0.30±0.33(Predicted) |
存储条件 | Sealed in dry,2-8°C |
外观 | 粉末 |
颜色 | white to beige |
体外研究 | ML221 is a potent apelin/APJ functional antagonist, inhibiting apelin-13-mediated activation of APJ, with IC 50 s of 0.70 μM in the cAMP assay, and 1.75 μM in the β-arrestin assay, and EC 80 of 10 nM in both assays. ML221 is >37-fold selective over the closely related angiotensin II type 1 (AT1) receptor (IC 50 , >79 μM) in cells. ML221 displays limited cross reactivity against a range of GPCRs except the κ-opioid and benzodiazepinone receptors (<50/<70%I at 10 μM). |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.595 ml | 12.975 ml | 25.95 ml |
5 mM | 0.519 ml | 2.595 ml | 5.19 ml |
10 mM | 0.26 ml | 1.298 ml | 2.595 ml |
5 mM | 0.052 ml | 0.26 ml | 0.519 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!